Skip to content
Search

Latest Stories

Pharmacy owners ‘strongly disagree’ EA’s proposed waste charges

Pharmacy waste charges
gettyimages

Increased waste charges would put further pressure on the pharmacy sector which is already at "breaking point”

Community Pharmacy England (CPE) has voiced strong opposition to the Environment Agency’s (EA) proposals to increase waste charges, set to be implemented in April 2025.

The EA launched a consultation on these proposals from 11 November 2024 to 20 January 2025, seeking feedback on new regulatory charges for waste activities, including waste exemptions, a waste crime levy, and adjustments to hourly rates for certain activities.


The agency emphasised that these charge proposals are designed to fund regulatory work targeting waste crime.

In its response, CPE said that they “strongly disagree” with the proposed registration charge of £56 for waste exemptions, which would apply for a three-year period.

The CPE argued that such charges would “put further pressure on a sector that is already at breaking point” and they “have no ability to pass on costs to their NHS patients.”

“NHS community pharmacies are experiencing significant financial pressures due to chronic government underfunding and the current economic climate,” CPE stated.

“While other businesses are entitled to increase their charges to the public for services they offer, community pharmacies are not able to do this [as] NHS services are funded by the NHS/the government,” CPE stated.

The EA proposals also include a £30 compliance band charge for pharmacies registering under the ‘T28 waste exemption: sort and denature controlled drugs for disposal.’

This exemption allows pharmacies to denature and dispose of controlled drugs to comply with the Misuse of Drugs Regulations 2001.

CPE strongly disagreed that the T28 exemption in Band 3 should apply to NHS community pharmacies, stating that it is “unnecessary.”

The organisation explained that all community pharmacies are already registered with the General Pharmaceutical Council (GPhC) and the NHS, as required under their NHS contracts. The organization suggested that if charges are implemented, funding allocations should be negotiated to ensure pharmacies can meet these costs.

The CPE, in its response, said that it is unnecessary since all community pharmacies are already registered with the General Pharmaceutical Council (GPhC) and the NHS, as required under their NHS contracts.

“If any charge is to be levied funding allocation should be discussed to ensure that NHS community pharmacies can meet the charge,” the CPE suggested.

CPE also challenged the EA’s assertion that the proposed charges are affordable.

The EA considers a 10 per cent levy to be “a reasonable contribution,” as its economic analysis demonstrates that it will result in minimal financial impact on smaller enterprises, with worst-case impacts on revenue estimated at 0.07% and on profit at less than 0.4%."

However, CPE refuted this, insisting that “community pharmacies are not able to cope with any additional burdens unless they are funded by the NHS and agreed with the government.”

According to EA, illegal waste activity is estimated to cost nearly £1 billion to the taxpayer and legitimate industry.

The agency’s most recent waste crime survey revealed that 18 per cent of waste (34 million tonnes per year) may be managed illegally at some point in the waste cycle.

In its consultation, the EA highlighted that a significant number of operators register exemptions and do not comply, citing that 42 per cent of registrants inspected in 2022 were non-compliant.

Waste exemptions are abused to hide illegal waste activities creating wide-scale risk of pollution and harm to communities.

“Better monitoring of waste exemptions will help achieve the targets from the resources and waste strategy to deter criminals from operating in the waste management sector and enforce better environmental standards,” it added.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less